[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.27.7″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n
The startups were selected through an international call for applications that attracted 32 submissions, followed by a rigorous due diligence process, technical and scientific evaluation by the LAB+ team, and the development of a tailored strategic plan for each company.<\/p>\n
<\/p>\n
Meet the three startups joining the LAB+ company builder:<\/p>\n
<\/p>\n
In-Depth Focus<\/strong><\/p>\n <\/p>\n In-Depth Focus is developing a platform built around the DIVER microscope, a technology that enables oncologists and pathologists to analyze biological tissue in real time during surgery, helping them detect tumor cells immediately.<\/p>\n <\/p>\n The startup was created through a partnership between the Advanced Bioimaging Unit (UBA) at the Institut Pasteur de Montevideo, the Hospital de Cl\u00ednicas, and FOCUS. The project is led by Leonel Malacrida (PhD in Biology, with postdoctoral training in Biophysics and head of the UBA), Javier Schandy (electrical engineer, PhD in Wireless Communications, and CEO of FOCUS) and Luis Inchausti (head electrician at the IP Montevideo).<\/p>\n <\/p>\n Herellex<\/strong><\/p>\n <\/p>\n Herellex is harnessing bacteriophages\u2014viruses that infect and replicate inside bacteria\u2014to improve the diagnosis, monitoring, and treatment of tuberculosis, a disease that affects more than 10 million people worldwide each year.<\/p>\n <\/p>\n The company was founded by Agust\u00edn Seijo (CEO, physician, University of Buenos Aires), Florencia Payaslian (CSO, biologist and PhD in Biological Chemistry, University of Buenos Aires), and Mariana Piuri (scientific advisor, biologist and PhD in Biological Chemistry, with postdoctoral training at the University of Pittsburgh).<\/p>\n <\/p>\n GeneGebra<\/strong><\/p>\n <\/p>\n GeneGebra applies the principles of genomic algebra to optimize the storage and analysis of genomic data, transforming complex biological sequences into information that is more efficient, accessible, and useful for research. Genome analysis is a critical tool for disease diagnosis, precision medicine, and infectious disease surveillance.<\/p>\n <\/p>\n The startup\u2019s patented technology, combined with artificial intelligence agents, aims to democratize access to computational biology by streamlining complex workflows and significantly reducing the human, financial, and energy costs associated with genomic analysis.<\/p>\n <\/p>\n GeneGebra was founded by Xavier Berthet, a biotechnology engineer and PhD in Microbiology who previously served as Scientific Director of the Institut Pasteur of Dakar.<\/p>\n <\/p>\n